Ledger.Open graph →
SEC Form D · filed April 20, 2023

Alucent Biomedical, Inc

Offering
$11.2M
Sold
$11.2M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SALT LAKE CITY, UT
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

James Corbett · San Juan Capistrano, CADirectorDaniel Pelak · Aliso Viejo, CADirectorJulie Lautt · Salt Lake City, UTDirectorBruce Krattenmaker · Salt Lake City, UTExecKevin Warner · Salt Lake City, UTExecColin Jackson · Salt Lake City, UTExecMyles Greenberg · Stamford, CTExec · DirectorDavid Flicek · Salt Lake City, UTDirectorKatalin Kauser · Salt Lake City, UTExecNick Pappas · Boston, MADirectorJames Isaacson · Salt Lake City, UTExecHenry Hauser · Salt Lake City, UTExecJulie Lautt · Salt Lake City, UTDirectorJames Corbett · Aliso Viejo, CADirectorBruce Krattenmaker · Salt Lake City, UTExecKevin Warner · Salt Lake City, UTExecColin Jackson · Salt Lake City, UTExecMyles Greenberg · Quincy, MAExec · DirectorDavid Flicek · Salt Lake City, UTDirectorKatalin Kauser · Salt Lake City, UTExecDaniel Pelak · Raleigh, NCDirectorNick Pappas · Hopkinton, MADirectorJames Isaacson · Salt Lake City, UTExecHenry Hauser · Salt Lake City, UTExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗